Qilian International Holding Group Limited

NASDAQ:QLI

5.41 (USD) • At close August 9, 2024
Bedrijfsnaam Qilian International Holding Group Limited
Symbool QLI
Munteenheid USD
Prijs 5.41
Beurswaarde 38,681,500
Dividendpercentage 0%
52-weken bereik 1.776 - 6.69
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Zhanchang Xin
Website https://www.qlsyy.net

An error occurred while fetching data.

Over Qilian International Holding Group Limited

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies

Vergelijkbare Aandelen

Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc.

BOLT

0.648 USD

Oncolytics Biotech Inc. logo

Oncolytics Biotech Inc.

ONCY

0.958 USD

SCYNEXIS, Inc. logo

SCYNEXIS, Inc.

SCYX

1.27 USD

Bionomics Limited logo

Bionomics Limited

BNOX

0.595 USD

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

0.228 USD

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

1.21 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

1.79 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)